CABINET MEDICAL LORENT
ActiveSummary
The computed 12-month bankruptcy probability of CABINET MEDICAL LORENT is 3.1% (moderate). The 2025 annual accounts show equity of €171k and a net result of €51k. Equity is growing by ~29% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability92▼-3
Solvency88▼-11
Growth52=
Track record94
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 2.94 against 5.83 in 2024; short-term debt: 29.3% and cash: 85.5% of total assets), and 36.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-09-2026, 53 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
53 d late
2024
61 d late
2023
57 d late
2022
38 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€171k▲ 2.1%
2024 · €167k
2022: €64k
2023: €120k
2024: €167k
2022 → 2025
Total assets
€270k▲ 19.4%
2024 · €226k
2022: €79k
2023: €150k
2024: €226k
2022 → 2025
Net result
€51k▲ 6.5%
2024 · €47k
2022: €54k
2023: €56k
2024: €47k
2022 → 2025
Working capital
€154k▲ 3.7%
2024 · €149k
2022: €56k
2023: €114k
2024: €149k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€64k-€120k▲ 88.3%€167k▲ 39.6%€171k▲ 2.1%
Operating result€67k-€71k▲ 5.4%€61k▼ 13.7%€66k▲ 7.0%
Net result€54k-€56k▲ 4.8%€47k▼ 15.5%€51k▲ 6.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 7% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €270k
Fixed assets
€37k ▼ 21.4%
Current assets
€233k ▲ 30.1%
Equity and liabilities €270k
Equity
€171k ▲ 2.1%
Debt
€100k ▲ 68.1%
Debt's share of the balance-sheet total rises from 26.2% to 36.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€78k▲
2024 · €71k
Cash flow
€63k▲
2024 · €57k
Current ratio
2.94▼
2024 · 5.83
Debt to equity
0.58▲
2024 · 0.35
ROE
29.6%▲
2024 · 28.4%
ROA
18.7%▼
2024 · 20.9%
Interest coverage
49.51▼
2024 · 57.21
Debt ≤ 1 year
€79k▲
2024 · €31k
Debt > 1 year
€20k▼
2024 · €28k
Income taxes
€13k▲
2024 · €13k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet
Code20242025
Assets
Total assets20/58€226k€270k▲
Fixed assets21/28€47k€37k▼
Tangible fixed assets22/27€47k€37k▼
Plant, machinery and equipment23€2k€2k▼
Furniture and vehicles24€42k€34k▼
Other tangible fixed assets26€3k€2k▼
Current assets29/58€179k€233k▲
Amounts receivable within one year40/41€578€2k▲
Trade receivables40€578-
Other amounts receivable41-€2k
Cash at bank and in hand54/58€178k€231k▲
Deferred charges and accrued income490/1€1k€761▼
Equity and liabilities
Total equity and liabilities10/49€226k€270k▲
Equity10/15€167k€171k▲
Contributions10/11€10k€10k=
Profit (loss) carried forward14€157k€161k▲
Amounts payable17/49€59k€100k▲
Amounts payable after more than one year17€28k€20k▼
Financial debts170/4€28k€20k▼
Amounts payable within one year42/48€31k€79k▲
Current portion of amounts payable after more than one year42€8k€8k▲
Trade debts44€387€4k▲
Suppliers440/4€387€4k▲
Taxes, remuneration and social security45€22k€10k▼
Taxes450/3€22k€10k▼
Other amounts payable47/48€518€57k▲
Accrued charges and deferred income492/3€215€216▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€12k▲
Other operating charges640/8€3k€2k▼
Gross operating margin9900€74k€80k▲
Operating profit (loss)9901€61k€66k▲
Financial charges65/66B€1k€2k▲
Recurring financial charges65€1k€2k▲
Profit (loss) for the period before taxes9903€60k€64k▲
Income taxes67/77€13k€13k▲
Profit (loss) for the period9904€47k€51k▲
Profit (loss) for the period to be appropriated9905€47k€51k▲
Appropriation of the result
Profit (loss) to be appropriated9906€157k€208k▲
Profit (loss) brought forward from the previous period14P€110k€157k▲
Profit to be distributed694/7-€47k
Directors or managers695-€47k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 53 days late
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Weakest financial yearnet €47k ▼15.5%
Net result drops to €47k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €150kEq €167k ▲39.6%
3 profitable years in a row build equity to €167k.
26-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 57 days late
2023
31-12
Financial
Highest result since 2022net €56k ▲4.8%
Operating result €71k, net result €56k, both a record.
31-12
Financial
Equity above €100kEq €120k ▲88.3%
2 profitable years in a row build equity to €120k.
23-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dalhem · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chemin de l'Andelaine(BOM) 244607 DalhemGround area
1,133 m²
Building footprint
115 m²
Volume, LiDAR
813 m³
Parcel 62018B0156/00F000, Wallonia · tallest building 8.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
CABINET MEDICAL LORENT
since 20222.329.386.011
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62018B0156/00F000 | Wallonia | 1,133 m² | 1 · 115 m² | 8.6 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-03-2022
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.